 |
|
|
|
 |
|||
The long-anticipated Wall Street reform bill just passed the U.S. Senate and is heading for President Obama’s desk. It still has a number of the investor-protection and corporate-governance provisions we mentioned before, but we were recently reminded that even some of the headline issues — bank capital standards, systemic-risk oversight, derivatives regulation — have a [...]
Earlier this week, we looked at an unusual disclosure provision that was added to the Senate financial-regulation reform bill. But now that the Senate has passed the nearly 1,600-page legislation, with a 59-39 vote last night, it’s worth looking at some of its other, farther-reaching measures with the potential to reshape disclosure and corporate filings [...]
The 1990s and early 2000s saw a surge of concern over “blood diamonds” and other gemstones that had been mined and exported from war-torn regions of the world, often accompanied by horrific exploitation and cost in human life. A big part of that story was pressure on the diamond industry from outside — from consumers, [...]
One of the big sticking points on the road to President Obama signing the Affordable Health Care for America Act earlier today was the debate over so-called Cadillac health care plans. The Senate bill wanted to impose a hefty tax on these luxe plans and the House bill didn’t, out of some misplaced fear that [...]
While the rest of the country went back to work last week, Congress is just getting around to that task today and by most accounts healthcare is at the top of the agenda. But one company seems to have gotten an early start: Invacare (IVC) filed this 8K on Friday, which certainly caught our attention. [...]
RSS
